Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma
- 8 June 2016
- journal article
- Published by Elsevier BV in Journal of Dermatological Science
- Vol. 83 (3), 182-189
- https://doi.org/10.1016/j.jdermsci.2016.05.004
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Low Herpesvirus Entry Mediator (HVEM) Expression on Dermal Fibroblasts Contributes to a Th2-Dominant Microenvironment in Advanced Cutaneous T-Cell LymphomaJournal of Investigative Dermatology, 2012
- Insights into the regulation of protein abundance from proteomic and transcriptomic analysesNature Reviews Genetics, 2012
- Increased CCL18 expression in patients with cutaneous T‐cell lymphoma: association with disease severity and prognosisJournal of the European Academy of Dermatology and Venereology, 2012
- Up-Regulation of the Chemokine CCL18 by Macrophages Is a Potential Immunomodulatory Pathway in Cutaneous T-Cell LymphomaThe American Journal of Pathology, 2011
- Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviorsBlood, 2010
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- Cutaneous T-Cell Lymphoma: Roles for Chemokines and Chemokine ReceptorsJournal of Investigative Dermatology, 2009
- CD4+CD25+Foxp3+regulatory T cells induce alternative activation of human monocytes/macrophagesProceedings of the National Academy of Sciences of the United States of America, 2007
- CCR4 Expression by Atypical T Cells in Systemic Pilotropic Lymphoma: Its Behavior under Treatment with Interferon Gamma, Topical PUVA and Systemic RetinoidDermatology, 2004
- Phase II trial of interferon‐α‐2a plus psolaren with ultraviolet light A in patients with cutaneous T‐cell lymphomaCancer, 2002